Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived

Wade T. Iams; Christine M. Lovly

doi:10.1158/2159-8290.CD-18-0489

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
- Journal Press Releases
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
- Journal Press Releases
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

In the Spotlight

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived

Wade T. Iams and Christine M. Lovly

Wade T. Iams

1Division of Hematology/Oncology, McGaw Medical Center of Northwestern University, Chicago, Illinois.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christine M. Lovly

2Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: christine.lovly@vanderbilt.edu

DOI: 10.1158/2159-8290.CD-18-0489 Published July 2018

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: June 2018 to January 2021

	Abstract	Full-text HTML	PDF
Total	5888	2386	853

Cited By

Article Information

Volume 8, Issue 7, pp. 797-799

DOI

https://doi.org/10.1158/2159-8290.CD-18-0489

PubMed

29967074

Published By

American Association for Cancer Research

Print ISSN

2159-8274

Online ISSN

2159-8290

History

Published first July 1, 2018.

Author Information

Wade T. Iams1 and
Christine M. Lovly2,*

¹Division of Hematology/Oncology, McGaw Medical Center of Northwestern University, Chicago, Illinois.
²Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

↵*Corresponding Author:
Christine M. Lovly, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue South, 777 PRB, Nashville, TN 37232. Phone: 615-936-3457; Fax: 615-343-2973; E-mail: christine.lovly{at}vanderbilt.edu

View Full Text

PreviousNext

July 2018
Volume 8, Issue 7

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived

Message Subject (Your Name) has forwarded a page to you from Cancer Discovery

Message Body (Your Name) thought you would be interested in this article in Cancer Discovery.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived